Investing in Biotech: How to Profit from the Biopharmaceutical Revolution

Front Cover
Raincoast Books, 2002 - Business & Economics - 253 pages
Until the 1990s it barely existed, but biotech is now a multi-billion dollar industry producing windfall profits. Everyone is talking about human cloning, the genome project, and cures for cancer and AIDS, but what's believable? Investing in Biotech is for anyone interested in profiting from the drug-development sector of this new, knowledge-based economy. Suitable for either an individual with $1,000 to invest or a financial manager responsible for million-dollar accounts, Investing in Biotech helps the reader understand one of the most discussed, but least understood sectors of the new economy. It gets beyond the genetics jargon and teaches how to rate a company's chances in developing new medications or treatments for diseases and illnesses. If there's truth in the old adage "Invest in what you know," then Investing in Biotech will tell the potential investor everything necessary to make a profit in the new economy's healthiest sector.

About the author (2002)

Dr. David G. Harper is president and co-founder of BioVentures, a private consulting company that provides information and advice to the business and biotechnology communities. A university professor with 20 years experience teaching about the mechanics of disease, he did his post-doctoral fellowship at Cambridge University and continues to teach at the University of British Columbia in Vancouver.